title: The Liver Meeting 2013: a report from the 64th meeting of the American Association for the Study of the Liver (November 1-5, 2013 - Washington, D.C., USA).
abstract: With over 10,000 attendees from across the U.S. and beyond, the Liver Meeting 2013 was a big success, full of interesting scientific presentations and discussions, many of which directly related to therapies for hepatitis C virus infection. These included new information on drugs currently used for treating this disease, as well as preclinical findings with putative new therapeutics that are expected to improve outcomes for patients in the future. Information was also presented on other hepatic diseases, including hepatitis B and hepatocellular carcinoma, as well as other less common liver diseases. This report briefly reviews many of the new scientific findings coming from clinical and preclinical studies aimed at improving the care of patients suffering from hepatic conditions.
authors: Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com.
authors: X
authors: X
authors: Rabasseda
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy* / Q000503:physiopathology
keywords: Alcoholic hepatic disease; Hepatitis; Liver cancer; Liver fibrosis; Nonalcoholic steatohepatitis